We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
Datavault AI and Perpetuals Partner to Tokenize Commodities
about 2 hours ago
Unlock Veteran Talent: Free Hiring Pipeline in Texas
about 2 hours ago
Why Your Church's Stained Glass Takes 1.5 Years to Build
about 3 hours ago
Tempest Droneworx Names Dr. Dana Abramovitz CEO in Leadership Shift
about 7 hours ago
No Agenda Show Deconstructs 'Lunar Economy' Hype
about 13 hours ago
PreAxia Launches Zane: AI-Powered Personal Finance Platform
about 17 hours ago
HR News
Unlock Veteran Talent: Free Hiring Pipeline in Texas
about 2 hours ago
Amadeus Fire Extends Gerlitzki's Board Contract Early Through 2031
3 days ago
HRO Today's 2026 Talent Acquisition Summit Set for Atlanta
9 days ago
Steyr Motors Appoints Bjorn Krausmann as CFO to Drive Growth
10 days ago
HR Research Institute Forms 2026 Employee Productivity and Engagement Advisory Board
10 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 4 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 4 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 1 day
Rail Vision and Railserve Explore Expanded AI Rail Safety Deployments
about 1 hour ago
ParaZero Technologies Ramps Up DefendAir Production for Drone Defense
about 1 hour ago
Crypto News
SEC Delays Crypto Stock Exemptions Amid Wall Street Concerns
1 day ago
SOLOWIN HOLDINGS Eyes Stablecoin Integration in Bahrain Payments
2 days ago
Forward Industries to Join Russell 2000 and 3000 Indexes
3 days ago
Iran Launches Crypto-Powered Maritime Insurance for Hormuz Shipping
7 days ago
Tokenized Real-World Assets Near $30B but Largely Untapped in DeFi
8 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 4 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 4 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 1 day
Regentis Targets $3B Market with Off-the-Shelf Knee Cartilage Repair
about 19 hours ago
Silent Killer: High Blood Pressure Crisis in AANHPI Communities
about 21 hours ago
Technology News
ParaZero Technologies Ramps Up DefendAir Production for Drone Defense
about 1 hour ago
Redwood AI to Acquire Quantum.IQ, Bolstering Quantum Cybersecurity
about 1 hour ago
Tempest Droneworx Names Dr. Dana Abramovitz CEO in Leadership Shift
about 7 hours ago
Hong Kong Exports Surge 42.9% in April 2026 on AI Demand
about 22 hours ago
HOA Start: Reclaiming Time and Continuity for Self-Managed Boards
about 23 hours ago
Events & Conferences
Unlock Veteran Talent: Free Hiring Pipeline in Texas
about 2 hours ago
Amadeus Fire AG AGM Approves New Capital and Strategy
about 18 hours ago
CTS EVENTIM Posts Strong Q1 2026 Growth in Revenue and EBITDA
about 18 hours ago
ROTH London 2026: B2i Digital Powers Growth Companies & Investor Connections
about 18 hours ago
Arlington: The North Texas Corridor Nobody's Talking About
about 23 hours ago